BU-LAD
From Wikipedia, the free encyclopedia
 |
|
 |
|
| Clinical data | |
|---|---|
| Routes of administration |
Oral |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Excretion | Renal |
| Identifiers | |
|
Systematic (IUPAC) name: (6aR,9R)-7-butyl-N,N-diethyl-4,6,6a,7,8,9- hexahydroindolo[4,3-fg]quinoline-9-carboxamide
|
|
| Synonyms | BU-LAD, 6-butyl-6-nor-Lysergic acid diethylamide |
| CAS Number | 96930-87-9  |
| PubChem (CID) | 44457782 |
| ChemSpider | 21106266  |
| ChEMBL | CHEMBL22520 |
| Chemical and physical data | |
| Formula | C23H31N3O |
| Molar mass | 365.512 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (what is this?) (verify) |
|
BU-LAD, also known as 6-butyl-6-nor-lysergic acid diethylamide, is an analogue of LSD first made by Alexander Shulgin and reported in the book TiHKAL. BU-LAD is a psychedelic drug similar to LSD, but is significantly less potent than LSD,[1] with a dose of 500 micrograms producing only mild effects.
References[edit]
- ^ Hoffman AJ, Nichols DE (September 1985). "Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives". Journal of Medicinal Chemistry. 28 (9): 1252–5. doi:10.1021/jm00147a022. PMID 4032428.
 |
This Hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
